[Multiple endocrine neoplasia 1 (MEN 1)].

Area of Science:

• Genetics and Molecular Biology
• Endocrinology
• Oncology

Context:

• Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant inherited cancer syndrome.
• MEN 1 is characterized by tumors of the parathyroid glands, enteropancreatic endocrine tissues, and anterior pituitary.
• The MEN 1 gene, located on chromosome 11q13, was identified in 1997 and encodes the MENIN protein.

Purpose:

• To review the current understanding of the MEN 1 gene and its associated protein, MENIN.
• To highlight the challenges in establishing a correlation between MEN 1 mutations and clinical data.
• To emphasize the potential of DNA testing for early diagnosis and treatment of MEN 1.

Summary:

• The MEN 1 gene has 10 exons and encodes a 610 amino acid protein, MENIN.
• Numerous germline mutations in the MEN 1 gene have been identified, but no mutation hotspot has been found.
• Recent research has shed light on the potential functions of the MENIN protein.

Impact:

• Understanding MEN 1 gene mutations is crucial for diagnosing and managing this familial cancer syndrome.
• Establishing correlations between MEN 1 mutations and clinical outcomes can improve patient care.
• DNA testing for MEN 1 mutations facilitates timely diagnosis and therapeutic interventions, potentially improving patient prognosis.